The participants of the "Future Directions in Cancer Prevention & Control: Workforce Implications for Training, Practice, & Policy" symposium paid tribute at a special event to one of the major shapers of the cancer prevention and control workforce of the last 25 years, Dr. Robert M. Chamberlain. Dr. Chamberlain's contributions to training and mentoring junior scientists in the field have resulted in the creation of generations of productive, well-prepared cancer prevention and control researchers and practitioners.
Dr Houston (1976 Houston ( -1979 and coordinator of the Cancer Prevention Training Program and research assistant professor in the Education Division of the Debakey Heart Center at Baylor College of Medicine (1979 Medicine ( -1988 Since 1996, Dr. Chamberlain has been the principal investigator, a co-investigator, or a co-director for eight funded research projects and a grant reviewer for several study sections. He is an associate editor for the Journal of Cancer Education and a reviewer for Cancer Epidemiology Biomarkers & Prevention. His publications number more than 65 articles published in peer-reviewed journals, seven manuals, two invited articles, two book chapters, and a book over his career. His professional memberships include the American Sociological Association; American Public Health Association; American Association for Cancer Education, of which he is a past president; the American Society for Preventive Oncology; Society for Clinical Trials; Society for Behavioral Medicine; and the European Association for Cancer Education.
Dr. Chamberlain's extensive international collaborations began with his first visit to Egypt in 1996. He has visited Egypt 18 times over the years and has established strong educational and research collaborations with many Egyptian cancer educators, cancer centers, and universities. He was awarded the medal of Cairo University in 2010 for his achievements and outstanding contributions in strengthening the academic relationship between Egypt and the USA. Dr. Chamberlain has been an active member of the Middle East Cancer Consortium (MECC) since 1998. MECC is funded by NCI to promote cancer research and educational activities of its member countries (Egypt, Cyprus, Israel, Jordan, Palestine, and Turkey As one of the most influential and productive rainmakers in the field of cancer prevention over more than two decades, Dr. Chamberlain's contributions cannot be numbered. We dedicate the symposium and this supplement to him.
